Crossmark

Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review

Crossref DOI link: https://doi.org/10.1007/s10585-022-10181-8

Published Online: 2022-08-02

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Löhr, J.-Matthias
License Information

Text and Data Mining valid from 2022-08-02

Version of Record valid from 2022-08-02
More Information

Article History

Received: 29 June 2022

Accepted: 26 July 2022

First Online: 2 August 2022

Declarations

:

: I am on the board of directors of PharmaCyte Biotech Inc., the company developing the CYP2B1 encapsulated cell therapy.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below